Variant report

Variant	nsv892623
Chromosome Location	chr9:15079847-15127129
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:15117708..15120327-chr9:15124924..15126439,2	MCF-7	breast:
2	chr9:15104683..15105453-chr9:15134855..15135757,5	MCF-7	breast:
3	chr9:15117708..15120327-chr9:15124924..15126439,2	MCF-7	breast:
4	chr9:15114564..15116499-chr9:15140559..15143275,2	MCF-7	breast:
5	chr9:15117245..15119080-chr9:15120315..15121968,2	K562	blood:
6	chr9:15117245..15119080-chr9:15120315..15121968,2	K562	blood:
7	chr9:15104494..15105436-chr9:15134860..15135453,3	MCF-7	breast:
8	chr9:15098843..15101225-chr9:15422041..15424261,2	MCF-7	breast:
9	chr9:15104624..15105430-chr9:15416660..15417504,2	MCF-7	breast:
10	chr9:15111864..15114810-chr9:15116682..15119632,2	K562	blood:
11	chr9:15111864..15114810-chr9:15116682..15119632,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000164975	chromatin interactions

Extended variants
information (count: 2463 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:2463 , 50 per page) page: 1 2 3 4 5 6 7 ... 50

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10961870	chr9:15079847-15079848	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs547434373	chr9:15079918-15079919	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs150031311	chr9:15079925-15079926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs145414817	chr9:15079965-15079966	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs554725799	chr9:15080014-15080015	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs554781393	chr9:15080020-15080021	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs187555852	chr9:15080045-15080046	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs537676171	chr9:15080052-15080053	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs78530522	chr9:15080062-15080063	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs372597454	chr9:15080083-15080084	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs577658193	chr9:15080089-15080090	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs116872296	chr9:15080121-15080122	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs149210148	chr9:15080137-15080138	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs375921332	chr9:15080167-15080168	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs115576298	chr9:15080233-15080234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs72614225	chr9:15080254-15080255	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs560850070	chr9:15080256-15080257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs553929875	chr9:15080277-15080278	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs531389884	chr9:15080313-15080314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs543255032	chr9:15080324-15080325	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs79149955	chr9:15080331-15080332	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs67131413	chr9:15080339-15080340	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs574233802	chr9:15080340-15080341	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs116327905	chr9:15080410-15080411	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs10738385	chr9:15080437-15080438	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs144987729	chr9:15080451-15080452	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs111322236	chr9:15080475-15080476	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs190519780	chr9:15080477-15080478	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs182678992	chr9:15080480-15080481	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs187003510	chr9:15080484-15080485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs571064824	chr9:15080492-15080493	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs191745301	chr9:15080512-15080513	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs556566161	chr9:15080519-15080520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs576381427	chr9:15080521-15080522	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs36010395	chr9:15080527-15080528	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs553410278	chr9:15080547-15080548	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs7031582	chr9:15080588-15080589	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs184535086	chr9:15080609-15080610	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs554642279	chr9:15080650-15080651	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs35270141	chr9:15080651-15080652	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs75360310	chr9:15080684-15080685	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs575782272	chr9:15080690-15080691	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs561986632	chr9:15080694-15080695	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs75594528	chr9:15080695-15080696	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs62536825	chr9:15080697-15080698	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs564698891	chr9:15080730-15080731	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs527438387	chr9:15080772-15080773	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs368914825	chr9:15080813-15080814	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs532191135	chr9:15080815-15080816	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs541291205	chr9:15080816-15080817	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21611746	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	19835627	CNVD

Chromatin state (count:230 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:15076200-15080000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr9:15076200-15080000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr9:15077200-15084200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
4	chr9:15078000-15082000	Enhancers	HepG2	liver
5	chr9:15078800-15080000	Weak transcription	Pancreas	Pancrea
6	chr9:15079800-15080200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr9:15079800-15085400	Weak transcription	Fetal Lung	lung
8	chr9:15080000-15080200	Enhancers	ES-I3 Cell Line	embryonic stem cell
9	chr9:15080000-15080200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr9:15080000-15080600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr9:15080000-15080600	Enhancers	Pancreas	Pancrea
12	chr9:15080000-15080800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr9:15080200-15086400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
14	chr9:15080600-15081000	Weak transcription	Pancreas	Pancrea
15	chr9:15080800-15081400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr9:15081000-15082400	Enhancers	Pancreas	Pancrea
17	chr9:15081400-15081600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr9:15084200-15084600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
19	chr9:15084600-15086600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
20	chr9:15085000-15085400	Enhancers	Fetal Muscle Trunk	muscle
21	chr9:15085000-15087200	Enhancers	Fetal Stomach	stomach
22	chr9:15085400-15088200	Enhancers	Fetal Lung	lung
23	chr9:15085800-15086000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr9:15086000-15087200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr9:15086200-15086600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr9:15086200-15087000	Enhancers	H9 Cell Line	embryonic stem cell
27	chr9:15086200-15087000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr9:15086200-15087600	Enhancers	NHDF-Ad	bronchial
29	chr9:15086400-15086800	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr9:15086400-15087000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr9:15087000-15087400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr9:15087200-15087800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr9:15088200-15096800	Weak transcription	Fetal Lung	lung
34	chr9:15095800-15096000	Enhancers	Small Intestine	intestine
35	chr9:15096600-15096800	Enhancers	Placenta	Placenta
36	chr9:15096800-15097600	Enhancers	Fetal Lung	lung
37	chr9:15097600-15098600	Weak transcription	Fetal Lung	lung
38	chr9:15098600-15100000	Enhancers	Fetal Lung	lung
39	chr9:15099000-15100600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr9:15099200-15101200	Enhancers	HepG2	liver
41	chr9:15100000-15100200	Weak transcription	Placenta	Placenta
42	chr9:15100000-15100400	Enhancers	iPS-15b Cell Line	embryonic stem cell
43	chr9:15100000-15100400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr9:15100000-15100600	Enhancers	Colon Smooth Muscle	Colon
45	chr9:15100000-15101000	Enhancers	Fetal Kidney	kidney
46	chr9:15100000-15101200	Flanking Active TSS	Fetal Lung	lung
47	chr9:15100000-15101600	Enhancers	Fetal Heart	heart
48	chr9:15100000-15101600	Enhancers	Fetal Muscle Leg	muscle
49	chr9:15100000-15101800	Enhancers	Fetal Stomach	stomach
50	chr9:15100200-15100400	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links